Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
07 Mar 2017 FDA Approves Telotristat Ethyl for Carcinoid Syndrome Diarrhoea Endocrine and neuroendocrine tumours
06 Mar 2017 NICE Issues a Quality Standard in Diagnosis, Assessment and Management of Head and Neck Cancer Head and neck cancers
03 Mar 2017 EMA Recommends Granting a Marketing Authorisation for Pemetrexed Hospira UK Limited Lung and other thoracic tumours - Anticancer agents & Biologic therapy
02 Mar 2017 EMA Recommends Granting a Marketing Authorisation for Rolapitant Palliative and supportive care
01 Mar 2017 Association Between Gut Microbiome and Responses to Anti-PD-1 Therapy in Patients with Metastatic Melanoma Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
28 Feb 2017 EMA Recommends Extensions of Indication for Daratumumab Haematologic malignancies - Anticancer agents & Biologic therapy
27 Feb 2017 EMA Recommends Extensions of Indications for Dabrafenib and Trametinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
24 Feb 2017 FDA Approves Lenalidomide as Maintenance Therapy for Patients with Multiple Myeloma Following Autologous Stem Cell Transplant Haematologic malignancies - Anticancer agents & Biologic therapy
23 Feb 2017 NICE Issues Diagnostics Guidance on Molecular Testing Strategies for Lynch Syndrome in Patients with Colorectal Cancer Pathology/Molecular biology - Gastrointestinal cancers
22 Feb 2017 First Comprehensive Paediatric Haematology-Oncology Initiative Launched in Africa Bioethics, legal and economic issues - Cancer in Special Situations - Haematologic malignancies
21 Feb 2017 Phase II Study Supports Potential for Atezolizumab plus Bevacizumab for Locally Advanced or Metastatic Renal Cell Carcinoma Genitourinary cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
20 Feb 2017 FDA Accepts Two sBLAs for Pembrolizumab for Locally Advanced or Metastatic Urothelial Cancer in Cisplatin-Ineligible First-Line and Second-Line Post-Platinum Failure Treatment Settings Genitourinary cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
16 Feb 2017 EU Maltese Presidency on Fairer Pricing for Cancer Drugs Bioethics, legal and economic issues
15 Feb 2017 First-Line Treatment of EGFR and ALK Wild-Type Advanced/Metastatic NSCLC: Refined Endpoints and Statistical Analysis Plan in the Phase III MYSTIC Study Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
14 Feb 2017 European Patent Office Decision on Dasatinib Haematologic malignancies - Anticancer agents & Biologic therapy